Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $36.12 USD
Change Today +0.14 / 0.39%
Volume 319.4K
HAE On Other Exchanges
As of 8:04 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ronald G. Gelbman

Lead Director, Chairman of Governance & Compliance Committee and Member of Audit Committee,Haemonetics Corporation
AgeTotal Calculated CompensationThis person is connected to 37 board members in 3 different organizations across 2 different industries.

See Board Relationships


Mr. Ronald G. Gelbman, also known as Ron, served as an Advisor of CareGain Inc. Mr. Gelbman began his professional career at Johnson & Johnson in 1972. Mr. Gelbman's worldwide responsibilities included Health Care Systems, LifeScan, Ortho-Clinical Diagnostics and Therakos. He serves as the Chairman of Sarasota Family Young Men's Christian Association Inc. He served as Johnson & Johnson's Worldwide Chairman of the Health Systems and Diagnostics Group from 1998 to 2000. ...

Read Full Background

Corporate Headquarters*

400 Wood Road
Braintree, Massachusetts 02184

United States

Phone: 781-848-7100
Fax: --

Board Members Memberships*

Lead Director, Chairman of Governance & Compliance Committee and Member of Audit Committee


There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options45,846
Exercisable Options Value$504,232
Unexercisable Options10,353
Unexercisable Options Value$90,175
Total Value of Options$594,406
Total Number of Options56,199

Total Compensation*

Total Annual Cash Compensation$80,000
Total Calculated Compensation$249,986
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HAE:US $36.12 USD +0.14


Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Yutaro Shintaku President and Representative Director
Terumo Corporation
Ulf Mark Schneider Chairman of the Management Board - Fresenius Management Se, Chief Executive Officer of Fresenius Management Se and President of Fresenius Management Se
Fresenius SE & Co KGaA
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAEMONETICS CORP/MASS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at